Literature DB >> 24129779

IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg?

Francesca Capon1.   

Abstract

As IL36RN mutations are a cause of generalized pustular psoriasis (GPP), three recent investigations attempted to correlate the IL36RN genotype with GPP clinical presentations. These studies found that IL36RN mutations account for only a fraction of GPP cases presenting with concomitant psoriasis vulgaris (PV; common or typical psoriasis). Pathogenic alleles were also found in control populations, indicating that environmental triggers and/or modifier genes may contribute to the disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24129779     DOI: 10.1038/jid.2013.361

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  [Pustular psoriasis].

Authors:  P Weisenseel; D Wilsmann-Theis; C Kahl; K Reich; R Mössner
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

2.  IL36RN mutations underlie impetigo herpetiformis.

Authors:  Kazumitsu Sugiura; Naoki Oiso; Shin Iinuma; Hiromasa Matsuda; Masako Minami-Hori; Akemi Ishida-Yamamoto; Akira Kawada; Hajime Iizuka; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

Review 3.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

4.  Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.

Authors:  Yun Liang; Xianying Xing; Maria A Beamer; William R Swindell; Mrinal K Sarkar; Liza Wolterink Roberts; John J Voorhees; J Michelle Kahlenberg; Paul W Harms; Andrew Johnston; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2016-11-21       Impact factor: 10.793

Review 5.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

6.  AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking.

Authors:  Niovi Setta-Kaffetzi; Michael A Simpson; Alexander A Navarini; Varsha M Patel; Hui-Chun Lu; Michael H Allen; Michael Duckworth; Hervé Bachelez; A David Burden; Siew-Eng Choon; Christopher E M Griffiths; Brian Kirby; Antonios Kolios; Marieke M B Seyger; Christa Prins; Asma Smahi; Richard C Trembath; Franca Fraternali; Catherine H Smith; Jonathan N Barker; Francesca Capon
Journal:  Am J Hum Genet       Date:  2014-05-01       Impact factor: 11.025

Review 7.  IL-6 as a druggable target in psoriasis: focus on pustular variants.

Authors:  Andrea Saggini; Sergio Chimenti; Andrea Chiricozzi
Journal:  J Immunol Res       Date:  2014-07-13       Impact factor: 4.818

Review 8.  "Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis.

Authors:  Ranjitha Uppala; Lam C Tsoi; Paul W Harms; Bo Wang; Allison C Billi; Emanual Maverakis; J Michelle Kahlenberg; Nicole L Ward; Johann E Gudjonsson
Journal:  Cell Mol Immunol       Date:  2020-08-19       Impact factor: 11.530

9.  Discovery in genetic skin disease: the impact of high throughput genetic technologies.

Authors:  Thiviyani Maruthappu; Claire A Scott; David P Kelsell
Journal:  Genes (Basel)       Date:  2014-08-04       Impact factor: 4.096

Review 10.  Pustular psoriasis: pathophysiology and current treatment perspectives.

Authors:  Katie E Benjegerdes; Kimberly Hyde; Dario Kivelevitch; Bobbak Mansouri
Journal:  Psoriasis (Auckl)       Date:  2016-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.